Klaus Sindahl
Investor Relations Contact at HANSA BIOPHARMA AB
Profile
Klaus Sindahl is currently the Head of Investor Relations at Hansa Biopharma AB since 2019.
Prior to this, he worked at Novozymes A for 12 years from 2006 to 2018 as an Investor Relations Officer.
Klaus Sindahl active positions
Companies | Position | Start |
---|---|---|
HANSA BIOPHARMA AB | Investor Relations Contact | 28/04/2019 |
Former positions of Klaus Sindahl
Companies | Position | End |
---|---|---|
Novozymes A/S
Novozymes A/S Chemicals: SpecialtyProcess Industries Novozymes A/S engages in the research and development of biotechnology solutions, which produces industrial enzymes and microorganisms. Its business areas include agriculture, bioenergy, biopharma, food and beverage, household care, leather, pulp and paper, textile and wastewater solutions. The company was founded in 2000 and is headquartered in Copenhagen, Denmark. | Public Communications Contact | 31/12/2017 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
HANSA BIOPHARMA AB | Health Technology |
Private companies | 1 |
---|---|
Novozymes A/S
Novozymes A/S Chemicals: SpecialtyProcess Industries Novozymes A/S engages in the research and development of biotechnology solutions, which produces industrial enzymes and microorganisms. Its business areas include agriculture, bioenergy, biopharma, food and beverage, household care, leather, pulp and paper, textile and wastewater solutions. The company was founded in 2000 and is headquartered in Copenhagen, Denmark. | Process Industries |
- Stock Market
- Insiders
- Klaus Sindahl